首页 > 专家库
Yu Wan

领域:生物产业 学校:西南交通大学职称:

1. Tumor homotypic targeting biomimetic drug delivery nanosystems. 2. Perfluorocarbon modified peptide gene vectors. 3. Codelivery system for siRNA and chemotherapeutic drug to enhance tumor therapeutic efficacy by modulating tumor hypoxia....

具体了解该专家信息,请致电:027-87555799 邮箱 haizhi@uipplus.com

教育背景

2006—2010: Sichuan University, West China School of Pharmacy, Bachelor of Science 2010—2013: Sichuan University, West China School of Pharmacy, Master of Pharmaceutics 2013—2017: University of Queensland, School of Chemistry and Molecular Biosciences anࣺᯬ

工作经历

项目课题经历

论文、成果、著作等

(1) Yu Wan, Wei Dai, Istvan Toth*, Peter M. Moyle*, Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells, Acta Biomaterialia, 2017, 59: 257-268. (2) Yu Wan, Peter M. Moyle*, Pei Zhi Gn, Istvan Toth*, Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplexes for efficient cellular delivery, Nanomedicine-UK, 2017, 12(4): 281-293. (3) Yu Wan#, Peter M. Moyle*#, Michelle P Christie, Istvan Toth*, Nanosized, peptide-based multicomponent DNA delivery systems: optimization of endosome escape activity, Nanomedicine-UK, 2016, 11(8): 907-919. (4) Yu Wan, Peter M. Moyle*, Istvan Toth*, Endosome Escape Strategies for Improving the Efficacy of Oligonucleotide Delivery Systems, Curr Med Chem, 2015, 22(29): 3326-3346. (5) Jie Zheng#, Yu Wan#, Abdelbary Elhissi, Zhirong Zhang, Xun Sun*, Targeted Paclitaxel Delivery to Tumors Using Cleavable PEG-Conjugated Solid Lipid Nanoparticles, Pharm Res, 2014, 31(8): 2220-2233. (6) Yu Wan, Jianfeng Han, Gerui Fan, Zhirong Zhang, Tao Gong, Xun Sun*, Enzyme-responsive liposomes modified adenoviral vectors for enhanced tumor cell transduction and reduced immunogenicity, Biomaterials, 2013, 34(12): 3020-3030.

专利、著作版权等

声明:本站专家信息来源于各高校官网。